Biomark Diagnostics Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Public

  • Employees
  • 6

Employees

  • Stock Symbol
  • BUX

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $0.18
  • (As of Thursday Closing)

Biomark Diagnostics General Information

Description

Biomark Diagnostics Inc is a Canada-based oncology-focused company. It is engaged in the development of the early-stage cancer diagnostic technology platform. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early cancer treatment. Its research and development are focused on the role that metabolomics plays in early cancer detection. The company's objective is to commercialize its inventive technology. and strive to increase the predictive accuracy in early-stage cancer detection.

Contact Information

Website
www.biomarkdiagnostics.com
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 3851 Shell Road
  • Suite 130
  • Richmond, British Columbia V6X 2W2
  • Canada
+1 (604)
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Stock Exchange
CNQ
Vertical(s)
TMT, Life Sciences, Oncology
Corporate Office
  • 3851 Shell Road
  • Suite 130
  • Richmond, British Columbia V6X 2W2
  • Canada
+1 (604)

Biomark Diagnostics Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biomark Diagnostics Stock Performance

As of 17-Apr-2025, Biomark Diagnostics’s stock price is $0.18. Its current market cap is $16.4M with 90.9M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.18 $0.18 $0.13 - $0.23 $16.4M 90.9M 11.6K -$0.01

Biomark Diagnostics Financials Summary

As of 31-Dec-2024, Biomark Diagnostics has a trailing 12-month revenue of $113K.

In Thousands,
USD 		TTM 31-Dec-2024 FY 2024 31-Mar-2024 FY 2023 31-Mar-2023 FY 2022 31-Mar-2022
EV 13,110 20,718 13,501 14,985
Revenue 113 121 116 35
EBITDA (1,111) (684) (1,016) (976)
Net Income (1,383) (1,058) (1,391) (1,159)
Total Assets 611 806 541 1,179
Total Debt 381 596 609 841
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Biomark Diagnostics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biomark Diagnostics‘s full profile, request access.

Request a free trial

Biomark Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biomark Diagnostics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Biomark Diagnostics‘s full profile, request access.

Request a free trial

Biomark Diagnostics Acquisitions (3)

Biomark Diagnostics’s most recent deal was a Merger/Acquisition with Luger Minerals. The deal was made on 30-Oct-2014.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Luger Minerals 30-Oct-2014 Merger/Acquisition Holding Companies
Affinity Research Learning 01-Oct-2014 Merger/Acquisition Educational Software
Sierra Coastal Partners 14-Mar-2013 Merger/Acquisition Investment Banks
To view Biomark Diagnostics’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Biomark Diagnostics FAQs

  • When was Biomark Diagnostics founded?

    Biomark Diagnostics was founded in 2007.

  • Where is Biomark Diagnostics headquartered?

    Biomark Diagnostics is headquartered in Richmond, Canada.

  • What is the size of Biomark Diagnostics?

    Biomark Diagnostics has 6 total employees.

  • What industry is Biomark Diagnostics in?

    Biomark Diagnostics’s primary industry is Biotechnology.

  • Is Biomark Diagnostics a private or public company?

    Biomark Diagnostics is a Public company.

  • What is Biomark Diagnostics’s stock symbol?

    The ticker symbol for Biomark Diagnostics is BUX.

  • What is the current stock price of Biomark Diagnostics?

    As of 17-Apr-2025 the stock price of Biomark Diagnostics is $0.18.

  • What is the current market cap of Biomark Diagnostics?

    The current market capitalization of Biomark Diagnostics is $16.4M.

  • What is Biomark Diagnostics’s current revenue?

    The trailing twelve month revenue for Biomark Diagnostics is $113K.

  • What is Biomark Diagnostics’s annual earnings per share (EPS)?

    Biomark Diagnostics’s EPS for 12 months was -$0.01.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »